Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2765464, 10 pages
http://dx.doi.org/10.1155/2016/2765464
Review Article

Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis

Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key of Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Wuhan 430071, China

Received 14 June 2016; Revised 26 August 2016; Accepted 19 September 2016

Academic Editor: Renato Franco

Copyright © 2016 Kun Zou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Van Cutsem, X. Sagaert, B. Topal, K. Haustermans, and H. Prenen, “Gastric cancer,” The Lancet, 2016. View at Publisher · View at Google Scholar
  3. M. Tsujiura, D. Ichikawa, H. Konishi, S. Komatsu, A. Shiozaki, and E. Otsuji, “Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids,” World Journal of Gastroenterology, vol. 20, no. 12, pp. 3265–3286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. X.-L. Ma, Z.-L. Xiao, L. Liu et al., “Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 4, pp. 1137–1144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Lv, L. Gong, T. Zhang et al., “Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis,” Clinical & Translational Oncology, vol. 18, no. 3, pp. 322–330, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Huang, P. Gao, Y. Song et al., “Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer,” BMC Cancer, vol. 15, no. 1, article 202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-Y. Zhang, Z.-L. Dai, X.-W. Yin, S.-H. Li, S.-P. Li, and H.-Y. Ge, “Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer,” BMC Cancer, vol. 14, article 773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Huang, P. Gao, J. Sun et al., “Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis,” International Journal of Cancer, vol. 136, no. 1, pp. 21–33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-Y. Wang, J. Wei, Z.-Y. Zou, X.-P. Qian, and B.-R. Liu, “Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis,” Contemporary Oncology, vol. 19, no. 6, pp. 451–457, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Li, J. Gong, Q. Zhang et al., “Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer,” British Journal of Cancer, vol. 114, no. 2, pp. 138–145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Meulendijks, J. W. de Groot, M. Los et al., “Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: a multicenter phase 2 study,” Cancer, vol. 122, no. 9, pp. 1434–1443, 2016. View at Publisher · View at Google Scholar
  12. S. J. Lee, J. Lee, S. T. Kim et al., “Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer,” International Journal of Biological Markers, vol. 30, no. 4, pp. e382–e386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Okabe, S. Tsunoda, H. Hosogi et al., “Circulating tumor cells as an independent predictor of survival in advanced gastric cancer,” Annals of Surgical Oncology, vol. 22, no. 12, pp. 3954–3961, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Xia, C.-L. Song, J.-F. Liu, D. Wang, and X.-Y. Xu, “Prognostic value of circulating CD133+ cells in patients with gastric cancer,” Cell Proliferation, vol. 48, no. 3, pp. 311–317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Kubisch, A. De Albuquerque, D. Schuppan, S. Kaul, M. Schaich, and U. Stölzel, “Prognostic role of a multimarker analysis of circulating tumor cells in advanced gastric and gastroesophageal adenocarcinomas,” Oncology, vol. 89, no. 5, pp. 294–303, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Sclafani, E. Smyth, D. Cunningham, I. Chau, A. Turner, and D. Watkins, “A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers,” Clinical Colorectal Cancer, vol. 13, no. 2, pp. 94–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Uenosono, T. Arigami, T. Kozono et al., “Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer,” Cancer, vol. 119, no. 22, pp. 3984–3991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ito, H. Inoue, N. Sando et al., “Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study,” BMC Cancer, vol. 12, article 346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Matsusaka, K. Chìn, M. Ogura et al., “Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer,” Cancer Science, vol. 101, no. 4, pp. 1067–1071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Hiraiwa, H. Takeuchi, H. Hasegawa et al., “Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers,” Annals of Surgical Oncology, vol. 15, no. 11, pp. 3092–3100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Pituch-Noworolska, P. Kolodziejczyk, J. Kulig et al., “Circulating tumour cells and survival of patients with gastric cancer,” Anticancer Research, vol. 27, no. 1, pp. 635–640, 2007. View at Google Scholar · View at Scopus
  22. K. Kolostova, R. Matkowski, R. Gürlich et al., “Detection and cultivation of circulating tumor cells in gastric cancer,” Cytotechnology, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-T. Li, H. Liu, F.-P. Li et al., “Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: relevance to therapy response,” World Journal of Gastroenterology, vol. 21, no. 47, pp. 13259–13267, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Li, B. Zhang, Z. Zhang et al., “Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer,” BioMed Research International, vol. 2014, Article ID 981261, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Yuan, L. Chen, M. Li et al., “Isolation and characterization of circulating tumor cells from human gastric cancer patients,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 647–660, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” International Journal of Surgery, vol. 8, no. 5, pp. 336–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. K. B. Parmar, V. Torri, and L. Stewart, “Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints,” Statistics in Medicine, vol. 17, no. 24, pp. 2815–2834, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Asimit, A. Day-Williams, L. Zgaga, I. Rudan, V. Boraska, and E. Zeggini, “An evaluation of different meta-analysis approaches in the presence of allelic heterogeneity,” European Journal of Human Genetics, vol. 20, no. 6, pp. 709–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Peters, A. J. Sutton, D. R. Jones, K. R. Abrams, and L. Rushton, “Comparison of two methods to detect publication bias in meta-analysis,” The Journal of the American Medical Association, vol. 295, no. 6, pp. 676–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. K. Beeharry, W. T. Liu, M. Yan, and Z. G. Zhu, “blood markers detection technology: a leap in the diagnosis of gastric cancer,” World Journal of Gastroenterology, vol. 22, no. 3, pp. 1202–1212, 2016. View at Publisher · View at Google Scholar
  34. X. Huang, P. Gao, Y. Song et al., “Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis,” BMC Cancer, vol. 14, article 976, 2014. View at Publisher · View at Google Scholar · View at Scopus